AI Regulation Tracker / New law

Virginia's HB 481 Requires a Licensed Physician to Approve Every Prior-Authorization Denial, Effective July 1, 2026

Regulatory summary: House Bill 481, enacted in Virginia's 2026 Regular Session and generally effective July 1, 2026, prohibits a health insurance carrier from making an adverse determination on a prior-authorization request unless a qualified human clinician has reviewed and approved it. For prescription drugs, the reviewer must be a licensed physician, or.

A new Virginia law bars health insurers from denying a prior-authorization request unless a licensed physician has reviewed and approved the denial, with narrow carve-outs for a pharmacist, a mental health provider, or a dentist. The practical effect is that an automated system can no longer be the sole basis for a denial.

Primary source

By Anthony Guerriero, Founder, The Leveraged Years · Reviewed by The Leveraged Years Editorial Desk · Published July 9, 2026 · Last updated July 9, 2026

Virginia's HB 481 Requires a Licensed Physician to Approve Every Prior-Authorization Denial, Effective July 1, 2026 regulation briefing

The Leveraged Years AI Regulation Tracker

Key takeaways

The law fixes who is allowed to issue a prior-authorization denial. A carrier can no longer record an adverse determination unless a named, licensed clinician has reviewed and approved it. For prescription drugs the reviewer must be a licensed physician, or a licensed pharmacist if a physician is unavailable. For health care services the reviewer must be a licensed physician, or a licensed mental health provider for mental health services or a licensed dentist for dental services if a physician is unavailable. That requirement removes the option of a fully automated denial with no qualified human sign-off.
Physicians and clinicians who staff or contract for insurer utilization-review functions; health insurance carriers and their utilization-review vendors; medical-practice administrators and revenue-cycle teams who submit prior-authorization requests; vendors of automated or AI-assisted utilization-review software; and patients in Virginia whose care or medication depends on prior-authorization approval.
Status: Enacted.
If you operate or buy utilization-review automation, map every path that can produce a Virginia prior-authorization denial and insert a mandatory, logged clinician review-and-approval gate keyed to the service type. If you submit requests, start recording whether each Virginia denial names a qualifying reviewer, because a missing or mismatched reviewer is now a statutory defect you can raise.

Regulatory Briefing

Bindingness: Enacted state statute. HB 481 amends and reenacts sections 38.2-3407.15:2 and 38.2-3407.15:8 of the Code of Virginia. This is binding law on health insurance carriers, not a policy statement or a proposal. The enrolled bill carries a general effective date of July 1, 2026.
Scope: Health insurance carriers conducting prior authorization in Virginia for prescription drugs and for health care services, including mental health and dental services. It governs the adverse-determination step, meaning the point at which a carrier denies a prior-authorization request, and dictates who must review and approve that denial.
What Changed: The law fixes who is allowed to issue a prior-authorization denial. A carrier can no longer record an adverse determination unless a named, licensed clinician has reviewed and approved it. For prescription drugs the reviewer must be a licensed physician, or a licensed pharmacist if a physician is unavailable. For health care services the reviewer must be a licensed physician, or a licensed mental health provider for mental health services or a licensed dentist for dental services if a physician is unavailable. That requirement removes the option of a fully automated denial with no qualified human sign-off.
Who This Affects: Physicians and clinicians who staff or contract for insurer utilization-review functions; health insurance carriers and their utilization-review vendors; medical-practice administrators and revenue-cycle teams who submit prior-authorization requests; vendors of automated or AI-assisted utilization-review software; and patients in Virginia whose care or medication depends on prior-authorization approval.
Current Status: Enacted. Passed the 2026 Regular Session, signed into law by the Governor, and generally effective July 1, 2026.
Effective Date: July 1, 2026, as stated in the enrolled bill. Note that the drug-benefit prior-authorization provisions in section 38.2-3407.15:2 sit within a part of the Code that also carries reforms with a January 1, 2027 effective date, so carriers should confirm the precise operative date for each drug-benefit provision with counsel.
Primary Source: HB 481 enrolled bill and Fiscal Impact Statement, Virginia State Corporation Commission (published April 13, 2026), https://lis.blob.core.windows.net/files/1218645.PDF ; bill record at https://lis.virginia.gov/bill-details/20261/HB481 ; enacted text in Code of Virginia section 38.2-3407.15:8, https://law.lis.virginia.gov/vacode/title38.2/chapter34/section38.2-3407.15:8/
Secondary Analysis: NFP, Virginia Limits Prior Authorization for Prescription Drugs; BenefitsPro, Virginia becomes latest state to enact prior authorization reform legislation (Apr 13, 2026); Holland & Knight analysis of states regulating AI in health care.
Workflow Impact: Insurer utilization-review pipelines must route every proposed denial to a qualified licensed reviewer before it is issued. Automated triage can still narrow, flag, and recommend, but the adverse determination itself needs a documented human review and approval by the correct license type for the service. Practices submitting requests should expect denials to carry a reviewing clinician of record, which strengthens the basis for appeal when the wrong reviewer type or no clinician review is evident.
Operational Next Step: If you operate or buy utilization-review automation, map every path that can produce a Virginia prior-authorization denial and insert a mandatory, logged clinician review-and-approval gate keyed to the service type. If you submit requests, start recording whether each Virginia denial names a qualifying reviewer, because a missing or mismatched reviewer is now a statutory defect you can raise.
Last Verified: July 10, 2026

Date	Jurisdiction	Rule	Affected professionals	Status or effective date
2026-07-09	United States (Virginia)	The law fixes who is allowed to issue a prior-authorization denial. A carrier can no longer record an adverse determination unless a named, licensed clinician has reviewed and approved it. For prescription drugs the reviewer must be a licensed physician, or a licensed pharmacist if a physician is unavailable. For health care services the reviewer must be a licensed physician, or a licensed mental health provider for mental health services or a licensed dentist for dental services if a physician is unavailable. That requirement removes the option of a fully automated denial with no qualified human sign-off.	Physicians and clinicians who staff or contract for insurer utilization-review functions; health insurance carriers and their utilization-review vendors; medical-practice administrators and revenue-cycle teams who submit prior-authorization requests; vendors of automated or AI-assisted utilization-review software; and patients in Virginia whose care or medication depends on prior-authorization approval.	Enacted. Passed the 2026 Regular Session, signed into law by the Governor, and generally effective July 1, 2026.

Source File

Instrument: House Bill 481, Prior authorization; requiring physician review for denial (2026 Regular Session)
Authority: Commonwealth of Virginia, General Assembly; enforced through the State Corporation Commission Bureau of Insurance; enacted into the Code of Virginia
Date: Enrolled version; Fiscal Impact Statement published April 13, 2026; signed by the Governor; generally effective July 1, 2026
Citation: HB 481, amending and reenacting Code of Virginia sections 38.2-3407.15:2 and 38.2-3407.15:8; patron Delegate Destiny LeVere Bolling
Primary Source: https://lis.blob.core.windows.net/files/1218645.PDF ; https://lis.virginia.gov/bill-details/20261/HB481 ; https://law.lis.virginia.gov/vacode/title38.2/chapter34/section38.2-3407.15:8/
Corroboration: NFP, Virginia Limits Prior Authorization for Prescription Drugs; BenefitsPro, Virginia becomes latest state to enact prior authorization reform legislation (Apr 13, 2026); Holland & Knight analysis of states regulating AI in health care.

Frequently Asked Questions

Is Virginia HB 481 in force?

It is enacted law. HB 481 passed the 2026 Regular Session, was signed by the Governor, and carries a general effective date of July 1, 2026 in the enrolled bill. It amends sections 38.2-3407.15:2 and 38.2-3407.15:8 of the Code of Virginia.

Does HB 481 ban insurers from using AI in prior authorization?

No. The law does not mention AI and does not prohibit automated tools. It requires that a licensed physician, or a permitted alternate for the service type, review and approve any denial. Automation can assist and recommend, but it cannot be the sole basis for an adverse determination.

Who can approve a prior-authorization denial under the law?

For prescription drugs, a licensed physician, or a licensed pharmacist if a physician is unavailable. For health care services, a licensed physician, or a licensed mental health provider for mental health services or a licensed dentist for dental services if a physician is unavailable.

Does the requirement apply only to physicians?

The default reviewer is a licensed physician. The alternates are conditional, available only when a physician is unavailable, and each is limited to its clinical domain. There is no general substitute for physician review across all requests.

When exactly do the drug-benefit provisions take effect?

The enrolled bill states a general July 1, 2026 effective date. Because the drug-benefit section sits within a part of Virginia's Code that also carries reforms effective January 1, 2027, carriers should confirm the precise operative date for each drug-benefit provision with counsel rather than assume one date covers everything.